We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

34 hedge funds and large institutions have $23.9M invested in ALPS Medical Breakthroughs ETF in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 5

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

24% more capital invested

Capital invested by funds: $19.2M → $23.9M (+$4.63M)

21% more funds holding

Funds holding: 2834 (+6)

2.63% more ownership

Funds ownership: 14.69%17.33% (+2.6%)

1% less call options, than puts

Call options by funds: $597K | Put options by funds: $603K

Holders
34
Holders Change
+6
Holders Change %
+21.43%
% of All Funds
0.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
14
Reduced
5
Closed
4
Calls
$597K
Puts
$603K
Net Calls
-$6K
Net Calls Change
-$179K

SBIO Hedge Fund Activity: Q4 2017 in Review

34 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q4 2017, worth a combined $23.9M — up 24% from $19.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SBIO positions and 4 closed out — a net gain of 6 holders — while 14 added to existing stakes and 5 trimmed.

The largest buyer was Raymond James & Associates, adding an estimated $725K. The largest seller was Wells Fargo, cutting an estimated $268K.

  • 34 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q4 2017, up from 28 in Q3 2017.
  • Funds reported $23.9M of ALPS Medical Breakthroughs ETF stock for Q4 2017, up 24% quarter-over-quarter.
  • 10 funds opened new ALPS Medical Breakthroughs ETF positions in Q4 2017 and 4 closed out, a net change of +6 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q4 2017 was Raymond James & Associates, an estimated $725K added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q4 2017 was Wells Fargo, an estimated $268K sold.

Based on aggregated 13F filings for Q4 2017.